GRP
MBRX icon

Global Retirement Partners’s Moleculin Biotech MBRX Stock Holding History

Global Retirement Partners’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$178 – 3289
2022
Q4 		– Hold
0
– – – 2947
2022
Q3 		– Hold
0
– – – 2866
2022
Q2 		– Hold
0
– – – 2802
2022
Q1 		– Hold
0
– – – 2717
2021
Q4 		– Sell
-1
Closed -$1K – 1158
2021
Q3 		$1K Hold
1
– – ﹤0.01% 1908
2021
Q2 		$1K Hold
1
– – ﹤0.01% 1811
2021
Q1 		$1K Buy
+1
New +$1.83K ﹤0.01% 1723
2020
Q4 		– Hold
0
– – – 1682
2020
Q3 		– Hold
0
– – – 1567
2020
Q2 		– Hold
0
– – – 1542
2020
Q1 		– Hold
0
– – – 1499
2019
Q4 		– Hold
0
– – – 1547
2019
Q3 		– Hold
0
– – – 1525
2019
Q2 		– Hold
0
– – – 1522
2019
Q1 		– Hold
0
– – – 1466
2018
Q4 		– Hold
0
– – – 1404
2018
Q3 		– Hold
0
– – – 1402
2018
Q2 		– Hold
0
– – – 1472
2018
Q1 		– Hold
0
– – – 1423
2017
Q4 		– Hold
0
– – – 1386
2017
Q3 		– Hold
0
– – – 1181

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Global Retirement Partners's MBRX Position: Q1 2023 in Review

Global Retirement Partners held its Moleculin Biotech (MBRX) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

Global Retirement Partners first reported a position in MBRX in Q1 2021 and has held it in 3 quarters since. The position peaked at $1K in Q3 2021. 22 funds tracked by Wall St. Rank hold MBRX as of Q1 2023.

  • Global Retirement Partners held 0 shares of Moleculin Biotech worth $0 as of Q1 2023.
  • Global Retirement Partners left its Moleculin Biotech share count unchanged in Q1 2023.
  • Moleculin Biotech made up ﹤0.01% of Global Retirement Partners's portfolio in Q1 2023, its #3289 holding.
  • Global Retirement Partners first reported a position in Moleculin Biotech in Q1 2021 and has held it in 3 quarters since.
  • Global Retirement Partners's Moleculin Biotech position peaked at $1K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Moleculin Biotech as of Q1 2023.

Based on Global Retirement Partners's 13F filing for Q1 2023, filed 8 May 2023.